发明名称 CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
摘要 PROBLEM TO BE SOLVED: To provide: a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a carboxylic acid; and multiparticulate, controlled release oral solid formulations of levodopa comprising: i) a controlled release component comprising a mixture of levodopa, a decarboxylase inhibitor and a rate controlling excipient; ii) a carboxylic acid component; and iii) an immediate release component comprising a mixture of levodopa and a decarboxylase inhibitor.SOLUTION: A controlled release oral solid formulation of levodopa comprises: (a) levodopa; (b) a decarboxylase inhibitor; and (c) a carboxylic acid that is not the (a) component or the (b) component.
申请公布号 JP2015187178(A) 申请公布日期 2015.10.29
申请号 JP20150145033 申请日期 2015.07.22
申请人 IMPAX LABORATORIES INC 发明人 HSU ANN;JIM H KOU;LAMAN LYNN ALANI
分类号 A61K31/198;A61K9/16;A61K9/20;A61K9/28;A61K45/00;A61K47/12;A61P25/16 主分类号 A61K31/198
代理机构 代理人
主权项
地址